Anzeige
Mehr »
Donnerstag, 11.09.2025 - Börsentäglich über 12.000 News
Diese Aktie sichert sich Exklusiv-Partnerschaft mit Babcock für Ukraine-Defence - Neubewertung voraus?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3C4QB | ISIN: FI4000480454 | Ticker-Symbol: 0TN
Frankfurt
11.09.25 | 09:59
1,350 Euro
+0,37 % +0,005
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
BIORETEC OY Chart 1 Jahr
5-Tage-Chart
BIORETEC OY 5-Tage-Chart
RealtimeGeldBriefZeit
1,3501,38011:16

Aktuelle News zur BIORETEC Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
04.09.Bioretec adds Harvard orthopedic surgeon to scientific board2
04.09.Bioretec Appoints Dr. Christopher W. DiGiovanni to Scientific Advisory Board127Bioretec Ltd Press Release 4 September 2025 at 3 p.m. EET TAMPERE, Finland, Sept. 4, 2025 /PRNewswire/ -- Bioretec Ltd., a pioneer in bioresorbable orthopedic implants, today announced...
► Artikel lesen
02.09.Bioretec Appoints Jordy Winters as Vice President of OUS Sales to Accelerate International Growth570TAMPERE, Finland, Sept. 2, 2025 /PRNewswire/ -- Bioretec Ltd, a pioneer in absorbable orthopedic implants, announced today the appointment of Jordy Winters as Vice President of Sales...
► Artikel lesen
28.08.Bioretec Ltd: Notification in accordance with chapter 9, section 10 of the Securities Market Act on a change in holdings (W&M GmbH)3
27.08.Bioretec selects its next CEO2
BIORETEC Aktie jetzt für 0€ handeln
27.08.Bioretec Appoints Sarah van Hellenberg Hubar-Fisher as Chief Executive Officer267TAMPERE, Finland, Aug. 27, 2025 /PRNewswire/ -- Bioretec Ltd., a pioneer in absorbable orthopedic implants, announced today the appointment of Sarah van Hellenberg Hubar-Fisher as Chief Executive...
► Artikel lesen
14.08.Bioretec Ltd's Half-year report 2025: Strong support for future growth from a successful rights issue334TAMPERE, Finland, Aug. 14, 2025 /PRNewswire/ -- Bioretec Ltd Company announcement 14 August 2025 at 8.00 am EEST This company announcement is a summary of Bioretec Ltd's half-year report...
► Artikel lesen
11.07.René Eve appointed as Director of Operations of Bioretec Ltd.2
27.06.Bioretec Ltd adjusts the terms and conditions of its stock option programs due to the completed rights issue389TAMPERE, Finland, June 27, 2025 /PRNewswire/ -- Bioretec Ltd Company announcement 27 June 2025 at 8.00 am EEST As previously announced, Bioretec Ltd ("Bioretec" or the "Company") has...
► Artikel lesen
26.06.New shares of Bioretec Ltd registered with the trade register5
24.06.Final results of Bioretec Ltd's successful rights issue620TAMPERE, Finland, June 24, 2025 /PRNewswire/ -- Bioretec Ltd Company announcement 24 June 2025 at 18:30 EEST NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY...
► Artikel lesen
23.06.Inside information: Preliminary result of Bioretec Oy's rights issue253Bioretec Ltd Inside information 23 June 2025 at 12.30 EEST NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA...
► Artikel lesen
04.06.Bioretec Ltd publishes an exemption document relating to its rights issue305Bioretec Ltd Company announcement 4 June 2025 at 4:00 p.m. EEST NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES...
► Artikel lesen
02.06.XFRA CAPITAL ADJUSTMENT INFORMATION - 02.06.20251.002Das Instrument KOZ NO0003043309 KONGSBERG GRUPPEN NK 1,25 EQUITY wird cum Kapitalmassnahme gehandelt am 02.06.2025 und ex Kapitalmassnahme am 03.06.2025 The instrument KOZ NO0003043309 KONGSBERG GRUPPEN...
► Artikel lesen
28.05.Inside information: Bioretec Ltd's Board of Directors resolved on a rights issue of approximately EUR 9.2 million and publishes the terms and conditions of the fully guaranteed rights issue341Bioretec Ltd Inside information 28 May 2025 at 2.00 p.m. EEST NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES...
► Artikel lesen
20.05.New shares of Bioretec Ltd subscribed with option rights have been registered with the trade register473Bioretec Ltd Company announcement 20 May 2025 at 2.00 p.m. EEST TAMPERE, Finland, May 20, 2025 /PRNewswire/ -- An aggregate number of 60,000 new shares of Bioretec Ltd have been subscribed...
► Artikel lesen
15.05.Inside information: Sarah van Hellenberg Hubar-Fisher appointed interim CEO of Bioretec279Bioretec Ltd Inside information 15 May 2025 at 10.15 a.m. EEST TAMPERE, Finland, May 15, 2025 /PRNewswire/ -- Bioretec's Board of Directors has appointed MBA Sarah van Hellenberg Hubar-Fisher...
► Artikel lesen
15.05.Bioretec Ltd's business review Q1 2025: Strong net sales in the first quarter; CE approval with comprehensive indications received in January accelerates the future expansion of RemeOs products401Bioretec Ltd Company announcement 15 May 2025 at 8:00 a.m. TAMPERE, Finland, May 15, 2025 /PRNewswire/ -- This announcement summarizes Bioretec Ltd's business review for January-March...
► Artikel lesen
08.05.Inside information: Bioretec's CEO Alan Donze to resign288Bioretec Ltd Inside information 8 May 2025 at 6:45 p.m. EET TAMPERE, Finland, May 8, 2025 /PRNewswire/ -- The Board of Directors of Bioretec Ltd announces that the company's...
► Artikel lesen
21.03.Bioretec Ltd's Board of Directors has decided on a new option program for the CEO341Bioretec Ltd Company announcement 21st of March 2025 at 3:00 p.m. EET TAMPERE, Finland, March 21, 2025 /PRNewswire/ -- The Board of Directors of Bioretec Ltd has on 21st of March 2025...
► Artikel lesen
Weiter >>
35 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1